Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation Manesh R. Patel, M.D., Kenneth W. Mahaffey, M.D., Jyotsna Garg, M.S., Guohua Pan, Ph.D., Daniel E. Singer, M.D., Werner Hacke, M.D.,…
NEW YORK (Reuters Health) – Cardiac magnetic resonance (CMR) stress perfusion imaging for possible ischemia provides “robust” prognostic information regardless of patient sex, new research indicates. In the…
NEW YORK (Reuters Health) – Use of compression stockings during the day by patients with chronic venous insufficiency leads to a reduction in nighttime apnea episodes, a French…
NEW YORK (Reuters Health) – Pooled data suggest that cancer patients who are treated with sunitinib (Sutent; Pfizer) have about a 2-fold increased relative risk of developing high-grade…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of…
NEW YORK (Reuters Health) – Treatment of isolated diastolic hypertension in patients with cerebrovascular disease protects against major vascular events, according to results from the PROGRESS trial. “For…
NEW YORK (Reuters Health) – One in twenty ischemic strokes occurs within 60 days of withdrawal of antithrombotic agents, according to a report in the June 30th online…
NEW YORK (Reuters Health) – For STEMI patients with multivessel coronary disease undergoing primary percutaneous coronary intervention, outcomes are better when revascularization is targeted to just the culprit…
NEW YORK (Reuters Health) – Patients with aortic stenosis fare better when they’re treated with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), results of a population-based…
NEW YORK (Reuters Health) – Oral propranolol given for 6 months stops the growth of infantile hemangiomas and decreases their volume and coloration, according to the results of…